Delivery Order SPE2DB25D3012-SPE2DB25FWYSM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,433.30 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 20 mg capsules (100 count) on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,148.12 to AmerisourceBergen Drug Corp for the supply of Dexmethylphenidate ER 30 mg capsules (100 count) with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,135,189 units of Dexmethylphenidate ER 10 mg capsules. The $2,805.96 contract has an ultimate completion date of April 2, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical products from its corporate office located in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,852,096 units of Dexmethylphenidate ER 10 mg capsules. The contract has a potential value of $3,189.84 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not designated as a set-aside. This delivery order falls under a larger, single award indefinite...
- The U.S. government's Defense Logistics Agency (DLA) awarded a $1,046.82 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,561,655,726 units of the prescription drug Dexmethylphenidate ER 10 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,161.88, is for the supply of 4,568,060,828 units of Dexmethylphenidate ER 10 mg capsules. The contract has a period of performance through April 29, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,119,700 units of the drug dexmethylphenidate ER 20 mg. The $1,534.06 contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA potentially valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4,564,118,189 units of Dexmethylphenidate ER 20 mg capsules, a prescription medication. The contract is a firm fixed price delivery order with a ceiling value of $1,716.09 and a period of performance through April 1, 2024. Amerisourcebergen Drug...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of Dexmethylphenidate ER 20 mg capsules. The contract is a firm-fixed price delivery order with a ceiling value of $1,493.32 and a completion date of June 5, 2025. The contract is not set-aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide 4,564,118,671 units of Dexmethylphenidate ER 5 mg capsules in 100-count bottles. The $4,638.15 contract has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYSMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,169.62 to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 10 mg capsules (100 count). The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The parent IDC enables the contractor to supply a wide range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for dexmethylphenidate, a controlled-release stimulant medication commonly used in military and federal healthcare settings, exemplifies the routine pharmaceutical fulfillment operations conducted through this comprehensive contract vehicle. The competitively awarded IDC structure demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements while providing DLA with flexible access to essential medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/18/25 |